Biochemical and genetic aspects of mevalonate kinase and its deficiency.

[1]  Shunji Takahashi,et al.  A Gene Cluster for the Mevalonate Pathway from Streptomyces sp. Strain CL190 , 2000, Journal of bacteriology.

[2]  James R. Brown,et al.  Identification, Evolution, and Essentiality of the Mevalonate Pathway for Isopentenyl Diphosphate Biosynthesis in Gram-Positive Cocci , 2000, Journal of bacteriology.

[3]  K. Grzeschik,et al.  Mutations in the NSDHL gene, encoding a 3beta-hydroxysteroid dehydrogenase, cause CHILD syndrome. , 2000, American journal of medical genetics.

[4]  S. Perrey,et al.  Embryonic Lethality and Defective Neural Tube Closure in Mice Lacking Squalene Synthase* , 1999, The Journal of Biological Chemistry.

[5]  G. Bennett,et al.  Overexpression, purification, and characterization of the thermostable mevalonate kinase from Methanococcus jannaschii. , 1999, Protein expression and purification.

[6]  N. Aboushadi,et al.  Role of Peroxisomes in Isoprenoid Biosynthesis , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[7]  T. Tansey,et al.  Differential binding of proteins to peroxisomes in rat hepatoma cells: unique association of enzymes involved in isoprenoid metabolism. , 1999, Journal of lipid research.

[8]  H. Tabak,et al.  Import of proteins into peroxisomes. , 1999, Biochimica et biophysica acta.

[9]  M. Rolland,et al.  Identification of a mutation cluster in mevalonate kinase deficiency, including a new mutation in a patient of Mennonite ancestry. , 1999, American journal of human genetics.

[10]  J. Derry,et al.  Mutations in a Δ8-Δ7 sterol isomerase in the tattered mouse and X-linked dominant chondrodysplasia punctata , 1999, Nature Genetics.

[11]  A. Moser,et al.  Mutations in the gene encoding 3β-hydroxysteroid-Δ 8,Δ7-isomerase cause X-linked dominant Conradi-Hünermann syndrome , 1999, Nature Genetics.

[12]  H. Waterham,et al.  Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome , 1999, Nature Genetics.

[13]  P. Vreken,et al.  Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene. , 1998, American journal of human genetics.

[14]  D. S. Lin,et al.  Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome. , 1998, American journal of human genetics.

[15]  R. Wanders,et al.  Differential deficiency of mevalonate kinase and phosphomevalonate kinase in patients with distinct defects in peroxisome biogenesis: evidence for a major role of peroxisomes in cholesterol biosynthesis. , 1998, Biochemical and biophysical research communications.

[16]  R. Cenedella,et al.  Probing cataractogenesis associated with mevalonic aciduria. , 1998, Current eye research.

[17]  K. Gibson,et al.  Characterization of the mevalonate kinase 5'-untranslated region provides evidence for coordinate regulation of cholesterol biosynthesis. , 1998, Biochemical and biophysical research communications.

[18]  R. Winter,et al.  Clinical phenotype of desmosterolosis. , 1998, American journal of medical genetics.

[19]  S. Subramani.  Components involved in peroxisome import, biogenesis, proliferation, turnover, and movement. , 1998, Physiological reviews.

[20]  K. Gibson,et al.  Post-translational regulation of mevalonate kinase by intermediates of the cholesterol and nonsterol isoprene biosynthetic pathways. , 1997, Journal of lipid research.

[21]  K. Gibson,et al.  Identification of an Active Site Alanine in Mevalonate Kinase through Characterization of a Novel Mutation in Mevalonate Kinase Deficiency* , 1997, The Journal of Biological Chemistry.

[22]  H. Miziorko,et al.  Identification of Catalytic Residues in Human Mevalonate Kinase* , 1997, The Journal of Biological Chemistry.

[23]  K. Gibson,et al.  Regulatory Adaptation of Isoprenoid Biosynthesis and the LDL Receptor Pathway in Fibroblasts from Patients with Mevalonate Kinase Deficiency , 1997, Pediatric Research.

[24]  H. Miziorko,et al.  Identification and Functional Characterization of an Active-site Lysine in Mevalonate Kinase* , 1997, The Journal of Biological Chemistry.

[25]  M. Gelb,et al.  Differential Prenyl Pyrophosphate Binding to Mammalian Protein Geranylgeranyltransferase-I and Protein Farnesyltransferase and Its Consequence on the Specificity of Protein Prenylation* , 1997, The Journal of Biological Chemistry.

[26]  S. Krisans,et al.  Cell Compartmentalization of Cholesterol Biosynthesis a , 1996, Annals of the New York Academy of Sciences.

[27]  E. Malle,et al.  Cholesterol metabolism in cells with different peroxisomal defects. , 1996, Clinica chimica acta; international journal of clinical chemistry.

[28]  J. V. D. van der Meer,et al.  Unstimulated peripheral blood mononuclear cells from patients with the hyper-IgD syndrome produce cytokines capable of potent induction of C-reactive protein and serum amyloid A in Hep3B cells. , 1996, Journal of immunology.

[29]  H. Sahm,et al.  Glyceraldehyde 3-Phosphate and Pyruvate as Precursors of Isoprenic Units in an Alternative Non-mevalonate Pathway for Terpenoid Biosynthesis , 1996 .

[30]  S. Krisans,et al.  Compartmentalization of Cholesterol Biosynthesis , 1996, The Journal of Biological Chemistry.

[31]  J. Meer,et al.  Interferon‐γ and urine neopterin in attacks of the hyperimmunoglobulinaemia D and periodic fever syndrome , 1995, European journal of clinical investigation.

[32]  C. Schalkwijk,et al.  Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. , 1995, Blood.

[33]  H. Mandel,et al.  Reduced cellular cholesterol content in peroxisome-deficient fibroblasts is associated with impaired uptake of the patient's low density lipoprotein and with reduced cholesterol synthesis. , 1995, Journal of lipid research.

[34]  P. Casey,et al.  Protein farnesyltransferase: kinetics of farnesyl pyrophosphate binding and product release. , 1995, Biochemistry.

[35]  G. Kostner,et al.  Cholesterol biosynthesis in dermal fibroblasts from patients with metabolic disorders of peroxisomal origin , 1995, European journal of clinical investigation.

[36]  M. Nishimura,et al.  Cloning of a cDNA encoding tobacco ω-3 fatty acid desaturase , 1994 .

[37]  G A Keller,et al.  Mevalonate kinase is predominantly localized in peroxisomes and is defective in patients with peroxisome deficiency disorders. , 1994, The Journal of biological chemistry.

[38]  P. Weber,et al.  Lovastatin increases arachidonic acid levels and stimulates thromboxane synthesis in human liver and monocytic cell lines. , 1994, The Journal of clinical investigation.

[39]  H. Sahm,et al.  Isoprenoid biosynthesis in bacteria: a novel pathway for the early steps leading to isopentenyl diphosphate. , 1993, The Biochemical journal.

[40]  K. Gibson,et al.  Bile acid metabolism in three patients with mevalonic aciduria due to mevalonate kinase deficiency. , 1993, Clinica chimica acta; international journal of clinical chemistry.

[41]  H. Lehr,et al.  Decreased Plasma Ubiquinone-10 Concentration in Patients with Mevalonate Kinase Deficiency , 1993, Pediatric Research.

[42]  K. Sartor,et al.  Clinical and biochemical phenotype in 11 patients with mevalonic aciduria. , 1993, Pediatrics.

[43]  K. Gibson,et al.  Molecular cloning of human mevalonate kinase and identification of a missense mutation in the genetic disease mevalonic aciduria. , 1992, The Journal of biological chemistry.

[44]  R. Tanaka,et al.  Mevalonate kinase is localized in rat liver peroxisomes. , 1992, The Journal of biological chemistry.

[45]  H. Mandel,et al.  Infantile Refsum Disease: Gastrointestinal Presentation of a Peroxisomal Disorder , 1992, Journal of pediatric gastroenterology and nutrition.

[46]  Victoria J. Hodge,et al.  Normal cholesterol synthesis in human cells requires functional peroxisomes. , 1991, Biochemical and biophysical research communications.

[47]  G. Robinson,et al.  Cloning and characterization of ERG8, an essential gene of Saccharomyces cerevisiae that encodes phosphomevalonate kinase , 1991, Molecular and cellular biology.

[48]  E. Boltshauser,et al.  Infantile phytanic acid storage disease, a disorder of peroxisome biogenesis: a case report , 1990, Journal of the Neurological Sciences.

[49]  F. Karst,et al.  Isolation of the ERG12 gene of Saccharomyces cerevisiae encoding mevalonate kinase. , 1990, Gene.

[50]  K. Gibson,et al.  3-Hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured fibroblasts from patients with mevalonate kinase deficiency: differential response to lipid supplied by fetal bovine serum in tissue culture medium. , 1990, Journal of lipid research.

[51]  R. Tanaka,et al.  Purification and regulation of mevalonate kinase from rat liver. , 1990, The Journal of biological chemistry.

[52]  J. Goldstein,et al.  Regulation of the mevalonate pathway , 1990, Nature.

[53]  W. S. Simonet,et al.  Near normal levels of isoprenoid lipids in severe mevalonic aciduria. , 1988, Biochemical and biophysical research communications.

[54]  Roger Burrows,et al.  Cholesterol synthesis in rat liver peroxisomes. Conversion of mevalonic acid to cholesterol. , 1987, The Journal of biological chemistry.

[55]  K. Gibson,et al.  Mevalonic aciduria--an inborn error of cholesterol and nonsterol isoprene biosynthesis. , 1986, The New England journal of medicine.

[56]  H. Schierbeek,et al.  Mevalonic aciduria: an inborn error of cholesterol biosynthesis? , 1985, Clinica chimica acta; international journal of clinical chemistry.

[57]  J. Porter.  [8] Mevalonate kinase , 1985 .

[58]  W. O'Sullivan,et al.  An improved purification procedure, an alternative assay and activation of mevalonate kinase by ATP. , 1983, Biochimica et biophysica acta.

[59]  F. Karst,et al.  Ertosterol biosynthesis in Saccharomyces cerevisiae: mutants deficient in the early steps of the pathway. , 1977, Molecular & general genetics : MGG.

[60]  J. Gray,et al.  The inhibition of plant mevalonate kinase preparations by prenyl pyrophosphates. , 1972, Biochimica et biophysica acta.

[61]  W. Cleland,et al.  Purification and mechanism of action of hog liver mevalonic kinase. , 1970, The Journal of biological chemistry.

[62]  G. Popják.  [12] Enzymes of sterol biosynthesis in liver and intermediates of sterol biosynthesis , 1969 .

[63]  J. Porter,et al.  The inhibition of mevalonic kinase by geranyl and farnesyl pyrophosphates. , 1968, The Journal of biological chemistry.

[64]  H. Levy,et al.  Studies on the biosynthesis of cholesterol. 10. Mevalonic kinase and phosphomevalonic kinase from liver , 1960 .

[65]  T. Tchen.  Mevalonic kinase: purification and properties. , 1958, The Journal of biological chemistry.

[66]  G. Popják,et al.  Studies on the biosynthesis of cholesterol. 6. Coenzyme requirements of liver enzymes for synthesis of squalene and of sterol from DL-3-hydroxy-3-methyl-[2-14C] pentano-5-lactone. , 1958, The Biochemical journal.

[67]  T. Tchen.  ON THE FORMATION OF A PHOSPHORYLATED DERIVATIVE OF MEVALONIC ACID , 1957 .

[68]  K. Bloch,et al.  THE ENZYMATIC CONVERSION OF MEVALONIC ACID TO SQUALENE , 1957 .

[69]  K. Folkers,et al.  β-HYDROXY-β-METHYL-δ-VALEROLACTONE (DIVALONIC ACID), A NEW BIOLOGICAL FACTOR , 1956 .

[70]  J. Huff,et al.  THE UTILIZATION OF β-HYDROXY-β-METHYL-δ-VALEROLACTONE IN CHOLESTEROL BIOSYNTHESIS , 1956 .